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ABSTRACT  
TGF-β1 is the most related cytokine with the production of fibrotic tissue. It plays an important 
role on the production of collagen by fibroblasts and other types of cells. The inhibition of this 
cytokine has demonstrated to reduce fibrosis in various types of tissue. Biofunctionalization of 
dental and orthopedic implants with biomolecules enables modification of the physical, chemical 
and biochemical properties of their surfaces to improve its biological and clinical performance. . 
Our objective was to develop a reliable method to immobilize oligopeptides on Ti surfaces to 
obtain a surface with TGF-β1 inhibitory activity that will potentially minimize fibrotic 
encapsulation of implants during the process of osseointegration. We covalently immobilized 
TGF-β1 inhibitory P17-peptides on Ti surfaces and assessed by characterizing each step of the 
process that we successfully biofunctionalized the implant surfaces. High amounts of peptides 
were anchored and homogeneously distributed on the surfaces with mechanical and 
thermochemical stability after in vitro simulated challenges. Notably, the immobilized peptides 
retained their TGF-β1 inhibitory activity in vitro. Thus, these coatings represent a promising new 
approach for biofunctionalizing surfaces for inducing a fast and reliable osseointegration. 
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INTRODUCTION 
Implant surgery provokes a series of reactions from the host organism such as inflammation, 
wound healing, foreign body reaction and fibrosis 1,2. Transforming Growth Factor Beta 1 (TGF-
β1) has been proved to play an important role in the host reaction to the implant 3,4. Immediately 
after surgery, cells surrounding the implant increase the production of TGF-β1 5 entailing the 
production of collagen type I, which is the main component of the fibrous tissue. However, the 
beneficial or detrimental effects of TGF-β1 on the osseointegration of an implant are not yet 
clear 6-8. Endoosseous metallic implants are encapsulated by an undesirable fibrous tissue layer 
with thickness that depends on the virulence of the host reaction and micro-displacements 
between the implant and the bone bed 9,10. This formation of the fibrous tissue layer may lead to 
bad vascularization of peri-implant tissues and thus, low stability of the implant may occur. 
Borrás Cuesta et. al. developed a peptide, P17, that inhibits the TGF-β1 signaling pathway and as 
a result of that reduces fibrosis in liver injury in rats 11. P17 (H-KRIWFIPRSSWYERA-OH) is a 
TGF-β1 inhibitor peptide that binds TGF-β1 and blocks TGF-β1 interaction with cell receptors. 
Therefore, cells reduce the production of collagen type I and fibrotic reactions 12-14.  
Biofunctionalization of titanium surfaces opens new perspectives of development of titanium 
implants 15,16. Surface coatings made of biological molecules with known biological activities let 
to tailor the biochemical properties of implant surfaces having, therefore, a better control of 
biomaterials-tissue interactions 17,18. Biochemical modification of titanium surfaces using 
appropriate peptides can alter adhesion of specific cells on the surface, influence their 
differentiation rate, reduce healing times, and increase long-term stability of the implant 19,20. 
Biochemical modification of titanium surfaces can be achieved by a variety of different methods 
15,16
. These methods involve physical adsorption or chemical binding. Chemical binding is often 
 4
the chosen alternative due to the generation of an irreversible covalent bond between the surface 
and the immobilized molecule with high stability under the harsh in vivo environmental 
conditions. However, it is a more challenging process than physical adsorption as the 
immobilization method requires the formation of a specific, strong and stable bonds between the 
organic molecules and the inorganic substrate. Biochemical immobilization methods using 
organic linking molecules such as silanes 21,22, phosphonates 23,24,  thiols 24 and polyethylene 
glycol (PEG) 25 have been studied to decorate surfaces with biological molecules. 3-
aminopropyltriethoxy silane (APTES) has been widely used to tether bioactive peptides to a 
number of oxide surfaces 26,27. However, the use of this silane for this purpose relies on the 
esterification of the carboxylic groups of the peptides to form a covalent bond that immobilize 
them on the silanized surface. The ineffective esterification of the carboxylic groups entails 
polymerization of the peptide and possible racemization 28. 
Here, our objective was to modify titanium surfaces with a simple and reliable method to tether 
oligopeptides and thus form a stable bioactive coating. We present a 4 step process that 
covalently immobilizes TGF-β1 antagonistic peptides to titanium surfaces. Notably, we used 
malonic acid as crosslinker with the objective of obtaining a homogeneous peptide coverage of 
the surface by forming a selective covalent bond between the linker and primary amines of the 
peptide without polymerization and/or racemization. Our hypothesis is that a modified P17-
peptide (MP17) tethered on titanium surfaces retains P17’s TGF- β1 inhibitory activity. The 
clinical goal is preventing peri-implant fibrosis, which eventually is beneficial for implant 
osseointegration. 
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EXPERIMENTAL SECTION 
Materials 
Bars of 10 mm in diameter of commercially pure titanium grade 2 (Ti) were purchased from 
Daido Steel Co. (Nagoya, Japan). 96% ethanol and acetone were purchased from Panreac S.A 
(Barcelona, Spain). Sodium hydroxide (NaOH), 2-propanol, anhydrous toluene, anhydrous 
cyclohexane, 3-aminopropyltriethoxysilane (APTES), malonic acid (Mal), dimethyl formamide 
(DMF), N,N,N′,N′-Tetramethyl-O-(1H-benzotriazol-1-yl) uronium hexafluorophosphate 
(HBTU), N,N-Diisopropylethylamine (DIEA), Ethylenediaminetetraacetic acid (EDTA), 
glycine, methanol, sodium deoxycholate, Trizma base, Trizma hydrochloride, sodium dodecyl 
sulfate (SDS) and Bovine Serum Albumin (BSA)  were purchased from Sigma-Aldrich (St. 
Louis, MO). Fluorescent molecules, FITC cadaverine and 5-FAM-X,SE were purchased from 
Anaspec (Fremont, CA). Penicillin-streptomycin, L-glutamine, phosphate-buffered saline (PBS) 
and alpha minimum essential medium (α-MEM) were purchased from Gibco Life technologies 
(New York City, NY). Protease inhibitor cocktail, rabbit-anti-phospho-SMAD2 antibody and 
mouse-anti-rabbit peroxidase coupled secondary antibody were purchased from Cell Signaling 
(Danvers, MA). Chemiluminiscence detection kit Lumi-LightPLUS was purchased from Roche 
GmbH, (Mannheim, Germany).  Acrylamide:Bis (29:1), ammonium persulfate (APS), 
tetramethylethylenediamine (TEMED), bromophenol blue and dithiothreitol (DTT) were 
purchased form Bio-Rad (Hercules, CA). Human Recombinant TGF-β1 was purchased from 
Prospec (Ness-Ziona, Israel). MP17 peptide (H-KGGGGGKRIWFIPRSSWYERA-OH) is a 
peptide derivate from the P17 sequence with a lysine at the N-terminus aimed to directly react 
with the linker at the surface; followed by a chain of 5 glycines used to space the peptide from 
the surface and thus   increase P17 activity. MP17  was synthesized by solid-phase peptide 
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synthesis method 29 in an automatic APEX 396 multiple peptide synthesizer (Aapptec LLC and 
kindly furnished by Digna Biotech (Madrid, Spain).  
Methods 
Biofunctionalization process 
The preparation of the functionalized surfaces was performed by means of a 4 step process. The 
surface was first activated with sodium hydroxide (Step 1), subsequently silanized using 3-
aminopropyltriethoxysilane (APTES) (Step 2) and then crosslinked with malonic acid (Step 3). 
Finally the immobilization of amino-containing fluorescent labels or MP17 oligopeptide was 
performed (Step 4). 
Step1 (NaOH (St. 1)): Ti discs were grinded with silicon carbide and mirror polished (Ra ≤ 50 
nm) with subsequent alumina suspensions (1 µm and 0.05 µm mean size). After polishing, the 
samples were washed by subsequently 5 minutes of ultrasonication in ciclohexane, isopropanol, 
distilled water and acetone. The clean and polished titanium samples were immersed in NaOH 5 
mol/l at 60 ºC for 24 h to form reactive –OH groups on the surface. After etching, the samples 
were immersed in distilled water during 30 minutes three times, washed with acetone and dried 
with N2 30.  
Step 2 (APTES (St. 2)): The surfaces were then immersed in a 30 mM APTES solution in 
anhydrous toluene at 70ºC during 1h with agitation and nitrogen atmosphere. After silanization, 
the samples were sonicated in anhydrous toluene for 15 minutes to detach any loosen APTES 
molecules. Subsequently, the silanized samples were washed with ethanol, isopropanol, distilled 
water and acetone and dried with nitrogen.  
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Step 3 (Crosslink (St. 3)): Then, the silanized surfaces were treated by immersing them into a 
dimethylformamide (DMF) solution containing malonic acid (Mal) 10 mM, O-benzotriazole-
N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) 30 mM and di-
isopropylethylamine (DIEA) 100 mM. The crosslinker solution was used during 2 h at room 
temperature with agitation. Then the samples were washed in pure DMF twice.  
Step 4 (MP17, St. 4): Covalent conjugation of oligopeptides on Ti surfaces was accomplished by 
immersing overnight the treated Ti discs into a DMF solution containing 0.2 mM of the MP17 
peptide, or failing that, 0.2 mM of the fluorescent labels used for the fluorescence tests: the 5-
FAM-X,SE or the FITC cadaverine. Ti discs were rinsed with deionized water and acetone. 
Scanning electron Microscopy (SEM) 
The surfaces were studied by means of a scanning electron microscope (SEM) (Zeiss Neon40, 
Zeiss, Germany) with an acceleration voltage of 8.0 keV and a vacuum chamber pressure of 10-9 
mbar. 
Water contact goniometry 
Contact angle measurements were performed using the sessile drop method on a DM-CE1 
goniometer (Kyowa, Japan). 3 µl drops of distilled water were dispensed on the sample surfaces. 
Water contact angles were measured using the FAMAS software (Kyowa, Japan) after 30 s of 
water contact; ie., when water contact angles were stable, . 
Fluorescence Microscopy 
Characterization by fluorescence analysis of the effectiveness of the chemical route used to 
functionalize the treated surfaces was performed.  The samples were functionalized with 5-FAM-
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X,SE or FITC cadaverine fluorescence molecules instead of using MP17 peptides. The use of 
these two different labels, which have different functional groups, allowed us to determine 
whether covalent reactions were taking place on the surface. The use of MP17 conjugated with a 
fluorescent label at the N-terminus was not possible since the fluorescent molecules compete 
with the surface for the available amine groups of the peptide; therefore, the covalent reaction 
between the peptide and the surface would be hindered. 
A BX51 microscope (Olympus, USA) was used to obtain fluorescence pictures of the surfaces 
coated with label molecules. The microscope was equipped with a fluorescent lamp and an 
Olympus DP 25 (USA) digital camera. The exposure time for each taken picture was 2 s and all 
parameters were fixed to get comparable intensities. To obtain numeric values of fluorescence 
intensity the pictures were analyzed by means of Image J v1.45 software. Mean and standard 
deviation for fluorescence intensities of the different tested groups were analyzed.  
X ray Photoelectron Spectroscopy (XPS) 
XPS analysis was conducted with a Quantum 2000 spectrometer (Physical Instruments, USA) 
using a monochromated Al Kα beam of 1 mm spot size at 45º with respect to the analyzed 
surface and a step size of 1 eV (4 scans/sample). The high resolution analysis of the peaks of 
interest was performed at 0.1 eV step size (20 scans/sample). To detach any loosen molecules all 
samples were sonicated in distilled water for 2 hours prior the surface chemical analysis. 
Chemical composition and peak deconvolution were assessed using CASA XPS v. 2.3.16 
software (Teignmouth, UK). 
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Mechanical and chemical stability of the coatings 
All treated surfaces were mechanically challenged by ultrasonication in distilled water. Water 
contact angles and fluorescence visualization were performed after different times of 
ultrasonication. Chemical stability tests were performed immersing the different Ti samples in 
PBS at 37 ºC without sonication for different periods. The samples were analyzed by water 
contact goniometry before and after the thermochemical challenge. 
Spectroscopic Ellipsometry 
Ellipsometry is used to assess thickness of thin organic coatings when the roughness of the 
substrate is lower than the thickness of the investigated coating. For this reason, in this case we 
tested silicon wafers covered with a homogeneous titanium oxide layer that were purchased from 
the Nanotechnology Platform of the Parc Científic at the University of Barcelona (Barcelona, 
Spain). The coated wafers were activated by O2-plasma treatment for 5 minutes, which did not 
modify the original topography and roughness of the wafer samples. Measurements were 
performed on surfaces after each step of the functionalization process and 2 hours of 
ultrasonication in water. The ellipsometry tests were performed using a VASE spectroscopic 
ellipsometer (J.A. Wollam Co., USA). Angles of incidence of the beam were 60º and 75º and 
spectra were collected for 500 nm-1100 nm wavelength rage and 15 nm pass. The data was 
analyzed using the VASE software from the ellipsometer manufacturing company. Silicon and 
TiO2 refractive indexes (n) and extinction coefficients (k) at the software’s database were used 
for modeling the organic coatings with a Cauchy dispersion model 31-33. Theoretical thicknesses 
of the layers were calculated by means of Chemdraw 3D Pro (Cambridgesoft, UK). The different 
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molecules where drawn in 3 dimensions, respecting the theoretical distances and angles of the 
different atomic bonds present in the molecules.  
Western Blot analysis
 
MC3T3-E1 murine pre-osteoblast cells were cultured in serum free α-MEM. After 24 h, 0.7 
ng/ml of TGF-β1 were dissolved in the same medium, exposed to the different Ti surfaces and 
incubated at 37ºC for 30 minutes. Subsequently, the medium was transferred to the cells and 
incubated at 37ºC for 1 hour. Then cells were lysed with RIPA buffer (50 mM Tris- HCl, pH 7.6, 
150 mM NaCl, 0.25% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, plus protease inhibitors) 
and centrifuged (12.000 g, 10 min, 4°C). Total protein of supernatants was determined by the 
bicinchoninic acid assay (BCA Protein Assay; Pierce, Waltham, MA) and equal amounts were 
size-fractionized in SDS-PAGE under reducing conditions (100 V, 40 mA/gel), transferred to 
nitrocellulose membrane (60 V; 4°C, overnight) and stained with red-Ponceau. Membranes were 
blocked in TBS-T buffer (0.9% NaCl, 0.02 M Tris pH 7.5, 0.05% Tween-20, 5% BSA; 1 h; RT) 
previous to incubation with rabbit-anti-phospho SMAD2 antibody (1:500). Detection was 
performed with mouse-anti-rabbit peroxidase coupled secondary antibody in TBS-T buffer and 
an enhanced chemiluminiscence (ECL) kit (Amersham, GE Healthcare, Waukesha, WI, USA). 
Bands were quantified with a digital image analyser (Quantity One Quantitation SoftwareTM; 
Bio-Rad, Hercules, CA, USA) on unsaturated x-ray films. 
Statistical analysis 
Statistically significant differences (p<0.05) among groups were assessed using non-parametric 
Kruskal-Wallis and multiple comparison post-hoc Mann-Whitney tests.   
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RESULTS AND DISCUSSION 
Surface functionalization process 
A 4-step functionalization process was developed to covalently immobilize oligopeptides to Ti 
surfaces. Initially, a surface activation was conducted by means of alkaline etching of the 
titanium surface with NaOH. This process provided the surface with high polarity and thus 
reactivity due to formation of abundant hydroxyl groups. This was because the combination of a) 
a highly intricate nanotopography that notably increased the real surface area of the substrate 
(Figure 1, upper row) with b) a modification of the chemical nature of the substrates from a 
mixture of titanium oxides (TiO2, Ti2O3 and TiO) to a homogeneous sodium titanate (Na2Ti3O7) 
layer, as previously demonstrated 34,35  and shown here by the detection of a strong Ti4+ peak in 
the XPS spectrum (Fig. 1, lower row). The significant increase in hydrophilicity (significant 
decrease in water contact angle) of the surfaces treated with NaOH in comparison with the plain 
Ti surfaces (Figure 2) further confirmed the activation of the treated surfaces. 
The second step of the functionalization process consisted of the silanization of the activated 
titanium surfaces using APTES. As previously established, hydrolysis of the ethoxy groups of 
the APTES molecules and subsequent reaction with the surface OH groups leads to a 
polycondensation reaction to form Ti-O-Si and Si-O-Si bonds 19. Silanization significantly 
decreased surface wettability of the activated surfaces (Fig. 2) due to the presence of 
hydrophobic alkyl chains in the APTES molecules. The drastic change in water contact angles 
before (Step 1) and after silanization (Step 2) suggested that a large amount of APTES molecules 
were retained on the treated surfaces.  
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 In the third step of the functionalization process APTES silanized surfaces were innovatively 
treated with malonic acid as crosslinker and HBTU as coupling agent. Combined malonic acid 
and HBTU form an active diester that enables the nucleophilic-electrophilic reaction with the 
amino groups of APTES molecules. The later leads to the establishment of a stable amide bond 
between APTES and malonic acid molecules. This crosslinking process provides with a surface 
coated with active esters that can readily react with free amino groups of the oligopeptides, such 
as those provided by lysine residues in the peptide sequence as well as the peptide N-terminus. 
Thus, the fourth and final step was designed to enable specific immobilization of free-amine 
containing molecules to the titanium surface through the formation of a second amide bond 
between the malonic acid molecules and the oligopeptides. Since the peptide solution does not 
contain coupling agents polymerization of the peptide in solution is not feasible and use of strong 
bases is not needed, which avoids racemization 36,37.  The effective formation of amide bonds in 
Steps 3 and 4 of the functionalization process is critical for attaining a successful immobilization 
of the crosslinking and bioactive molecules, respectively. To investigate the effective formation 
of amide bonds we anchored two different fluorescent molecules, 5-FAM-X,SE and FITC 
cadaverine, as functional surrogates for the malonic acid-HBTU and free-amine containing 
peptide molecules, respectively. These two fluorescein derivatives differ in the functional group, 
which is a primary amine in the case of FITC cadaverine and a succinimidyl ester in the case of 
5-FAM-X,SE. Thus, 5-FAM-X,SE was anchored on the APTES-silanized surfaces and FITC 
cadaverine on surfaces with attached crosslinking molecules during Steps 3 and 4, respectively 
(Fig. 2 and 3). The resulting fluorescence intensities revealed that titanium surfaces retained 
notable amounts of the surrogate molecules during both Step 3 and 4 of the functionalization 
process. Higher intensities were assessed after Step 3 than after step 4, which can be attributed to 
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the additional strong electrostatic attraction between the APTES and 5-FAM-X,SE molecules 38. 
These surfaces showed high and stabile fluorescence intensities and correlated quasi constant 
water contact angles after sonication in water for periods longer than 3h (Figure 2). The later 
suggested that once all physisorbed molecules were released from the surface a significant 
amount of covalently bound molecules were successfully retained on the coating. Images 
obtained by fluorescence microscopy showed a homogeneous coating of the fluorescent 
molecules on the functionalized surfaces (Supplementary material). 
Confirmation of the effective covalent immobilization of fluorescent molecules with primary 
amines through the aforementioned specific reactions is shown in Figure 3. The tested groups of 
treated surfaces with the designed  potential to generate covalent bonds with fluorescent 
molecules; i.e, APTES with 5-FAM-X,SE (APTES(St. 2)-FAM) and malonic acid with FITC 
cadaverine (Crosslink(St. 3)-FITC), showed the highest stability of the fluorescence intensity 
after 20 h of sonication in water. However, the control groups with unspecific combinations of 
treated surfaces and fluorescent molecules did not retained a notable fluorescent signal after 20 
hours of sonication, which suggested that most of the fluorescent molecules were just 
physisorbed by weak electrostatic and/or hydrophobic interactions with the substrate 39,40. 
 
XPS results further confirmed the validity and effectiveness of the functionalization process. 
Table 1 displays the molar percentage composition of the surfaces after each step of the 
functionalization process. On plain Ti surfaces, as expected, oxygen, titanium and carbon were 
the main elements detected. The presence of carbon reflects adventitious contamination from the 
ambient environment which mainly consists on oxidized aliphatic chains 41. The high resolution 
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deconvolution of the Ti2p peak (Fig. 1) showed a small peak at low binding energy (453.3 eV), 
characteristic of metallic Ti. The most intense contribution was from Ti4+ (854.5 eV), which is 
characteristic of the passive layer formed on Ti surfaces that is rich in TiO2. Low signals for TiO 
(454.4 eV) and Ti2O3 (456.3eV) were also detected. After surface activation by NaOH etching, 
the carbon C1s signal dramatically decreased, which suggested a thorough surface cleaning 
during alkaline etching. The Na1s, O1s signals and the Ti/O ratio increased according to the 
generation of a thicker sodium titanate layer 42. Silanization of the activated surfaces generated 
increased carbon C1s signal from the aliphatic chains of the APTES molecules and nitrogen N1s 
signal from the functional terminal group of the silanes. After immobilization of the crosslinking 
molecules further increase of the carbon C1s was detected, which revealed the presence of 
malonic acid molecules. Most interestingly, an increase in the nitrogen signal was also assessed. 
This suggested that the malonic acid molecules were esterified by combination with the HBTU 
coupling agent. The deconvolution of the high resolution N1s peaks (Fig. 4) for the surfaces after 
Step 2 revealed that about half of the amino groups of the anchored APTES molecules were in its 
protonated form. After Step 3, the deconvolution of the high resolution N1s peak (Figure 4) 
proved the formation of the amide bonds (N-C=O) between the silanes and the malonic acid 
crosslinking molecules. The presence of these chemical groups was also assessed by DRIFTS 
(Supplementary information). 
Combined, all those results suggest that we successfully achieved the covalent immobilization of 
amino groups on titanium surfaces with high stability by a simple method that avoids peptide 
polymerization and racemization. 
MP17-peptide coatings  
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We designed MP17 peptide, a modified P17 peptide to improve covalent bonding and retention 
of bioactivity of the TGF-β1 inhibitor peptide. The modification consisted of the addition of a 
lysine residue at the N terminus of the peptide followed by a chain of five glycines. The lysine 
residue contains a free amino group to react with the active esters of the functionalized surface 
through the APTES-Malonic acid route that has been previously described. The five glycines 
between the first lysine and the biologically active sequence was introduced to space the P17 
sequence from the titanium surface as well as to allow mobility of the peptides as to improve the 
interfacial reactions with the biological entities; i.e., macromolecules and cells. Thus, retention 
of the biological efficiency of the peptide coatings was expected.  
The build-up and properties of the peptide coatings were assessed by immobilizing the MP17 
peptide on the functionalized titanium and analyzing the surfaces by means of contact angle 
goniometry, XPS, DRIFTS and spectroscopic ellipsometry.  
After immobilizing the MP17 on the functionalized surfaces, XPS surveys revealed an increase 
of the N1s and C1s signals as well as the O/Ti ratio (Table 1). This results suggested that a 
considerable amount of peptide was deposited on the surface. Deconvolution of the nitrogen N1s 
high resolution peak (Fig. 4) showed only one peak that corresponded to the peptide bonds and 
covalent amide bonds  (401 eV) and thus, the MP17 oligopeptide was covalent bonded to the 
surface. DRIFTS studies on the MP17 surfaces corroborated these results (Supplementary data). 
The thermalchemical stability of the MP17 coatings was evaluated by contact angle goniometry 
(Fig. 5). The coated surfaces were immersed in water at 37 ºC for 15 days and water contact 
angles on the challenged coatings were measured at different times. Even though we assessed a 
low-rate progressive reduction of the contact angle on all functionalized surfaces, after 15 days 
of incubation the surfaces were significantly less hydrophilic than after being activated by NaOH 
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etching. This result indicates that the peptide coatings were highly stable with strong retention of 
the bioactive molecules after such period of immersion time. The slight reduction in water 
contact angle with immersion time was most likely related to hydrolysis of silanol groups of the 
APTES molecules 43, which is the weakest link of the functionalization process.  
The Cauchy models for the spectroscopic ellipsometry results revealed the successful buildup of 
the coatings during the functionalization process (Figure 6). The calculated thickness of the 
formed APTES layer after 2 h of sonication in water (0.52 nm) indicated that a strongly retained 
silane monolayer was obtained on the titanium surface 27,38,44,45. After cross-linking with malonic 
acid+HBTU, the coating increased approximately 1 nm in thickness. This result correlates well 
with the theoretical atomic distances of the molecules present on the surface. After linking the 
MP17 peptide and 2 h of sonication in water, the thickness of the coating significantly increased 
due to the bonding and retention of the more bulky peptide molecules. The theoretical thickness 
of the MP17 coating was lower than the one calculated from the ellipsometry measurements and 
fitted to a Cauchy model. This result suggested the MP17 coatings were composed of a peptide 
multilayer, meaning that a physisorption process is always generated between the peptide and the 
surface, independently of whether a covalent reaction is taking place or not. The amount of 
peptide present on the surface was quantified to 36 nmol/cm2 (supplementary material) which 
suggests a multilayered peptide coating in correlation with the spectroscopic ellipsometry results. 
 
Bioactivity of MP17-peptide coatings 
High expression levels of phosphorilated SMAD2 (p-SMAD2) by cells when TGF-β1 is 
administered in MC3T3-E1 pre-osteoblast culture is the most reliable method to elucidate 
whether the TGF-β1 signaling pathway is activated. Figure 7 shows Western Blot results 
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demonstrating that the modified MP17 peptide was able to partially inhibit the activity of TGF-
β1 when both administered free in solution and, most notably, immobilized on the titanium 
surface with the developed functionalization process.  On titanium surfaces biofunctionalized 
with MP17 the expression of p-SMAD2 was significantly reduced in comparison with a non-
biofunctionalized surface. This inhibition effect was even stronger on cells cultured on non-
biofunctionalized titanium surfaces and exposed to the peptide in solution at high concentrations. 
Importantly, p-SMAD2 expression levels were very low but still detectable when exogenous 
TGF-β1 was not administered to the cells, which suggested an autocrine/paracrine activity of 
TGF-β1 on MC3T3-E1 pre-osteoblasts.  
These results validate our hypothesis that the MP17-peptide tethered on titanium surfaces 
displays TGF- β1 inhibitory activity. Thus, these coatings represent a promising new approach 
for biofunctionalizing surfaces for inducing fast and reliable osseointegration that will be further 
in vitro and in vivo tested.  
 
CONCLUSIONS 
A new route to covalently immobilize oligopeptides on titanium surfaces has been developed. 
The functionalization of Ti with APTES and malonic acid led us to generate amide bonds 
between the free amino groups of the peptide and the treated surfaces. The surfaces were 
mechanically and chemically stable due to the covalent bonds formed between the organic 
molecules and the metallic surface. Also, MP17, a modified version of P17, a TGF-β1 inhibitor 
peptide, was immobilized on titanium surfaces using this functionalization process and retained 
the biological activity; i.e., the MP17-coatings reduced the effect of TGF-β1 on MC3T3-E1 cells. 
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This approach opens new perspectives in the field of biofunctionalization of surfaces for hard 
tissue repair and can be also used in applications to investigate and direct the stem cell fate. . 
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Figure 1. Surface activation by alkaline etching. Upper row: SEM pictures of Ti surfaces 
before (left) and after (right), activation with NaOH etching. Lower row: deconvolution of the 
high-resolution XPS Ti2p peak of Ti surfaces before (left) and after (right) activation. 
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Figure 2. Effectiveness of the route of functionalization. Wettability (redish bars) and 
fluorescence intensity (greenish bars) of the treated Ti surfaces after different steps of the 
functionalization process. Results after different sonication periods are also shown. Plain Ti and 
NaOH treated samples were labeled with physisorbed FITC cadaverine molecules. APTES-
silanized surfaces (Step 2) and silanized surfaces with anchored crosslinker (Malonic acid) (Step 
3) were labeled with FAM-X(SE) and FITC cadaverine molecules, respectively to investigate the 
formation and stability of the covalent attachment of the fluorescent molecules.  
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Figure 3. Specificity and stability of the covalent reaction between treated titanium 
surfaces and fluorescent molecules.  Percentage of retained fluorescence intensity of treated 
titanium surfaces and coated with 5-FAM-X, SE or FITC cadaverine molecules between 
different times (0h-2h, and 2h-20h) of ultrasonication in water at room temperature. * and # 
indicates groups differences with statiscally significant differences (p<0,05). 
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Table 1. Chemical composition of treated surfaces. Quantification of chemical composition 
after each step of the functionalization process and final MP17 coating after ultrasonication for 
2h in water. 
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Figure 4: Analysis of amine and amide bonds after immobilization of molecules. 
Deconvolution of high resolution N1s peaks obtained by XPS on treated titanium surfaces after 
immobilization of APTES (A: APTES (St.2)), immobilization of malonic acid (B: Crosslink 
(St.3)), and immobilization of MP17 peptides (C: MP17 (St.4)). 
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Figure 5. Thermochemical staibility of the peptide coatings. Water contact angles of the 
treated titanium surfaces after different immersion times in water at 37 °C. 
 
  




	











 
!

"







 29
 
 
 
Figure 6. Thickness of coatings. Cauchy and theoretical thickness of the coatings after the 
different steps of the functionalization process from ellipsometry results. * indicates groups with 
no statistically significant differences (p≥0,05). 
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Figure 7. Bioactivity of MP17 peptides and coatings. Western Blot results for expression of p-
SMAD2 on MC3T3-E1 preosteoblasts. TGF-β1 row: + TGF-β1 was administered to the cells at 
0.7 ng/ml. - TGF-β1 was not administered (background control). MP17 row: + titanium surface 
was biofunctionalized with MP17-peptide. - titanium surface was not biofunctionalized. 200 
µg/ml, titanium surface was not biofunctionalized but MP17 was administered to the cells in 
solution at a concentration of 200 µg/ml.  
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